Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga09-04

Shares of GitLab Inc. (NASDAQ:GTLB) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and issued FY25 guidance above estimates.

GitLab reported quarterly earnings of 15 cents per share, which beat the analyst consensus estimate by 50%. Quarterly revenue came in at $182.6 million, which beat the analyst consensus estimate of $176.889 million by 3.23%.

GitLab shares jumped 16.8% to $52.21 in the pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • WiSA Technologies, Inc. (NASDAQ:WISA) gained 63.2% to $2.22 in pre-market trading as the company said it has executed a definitive asset purchase agreement to purchase the Datavault® intellectual property and information technology assets of privately held Data Vault Holdings Inc.
  • Conifer Holdings, Inc. (NASDAQ:CNFR) rose 39.1% to $1.60 in today's pre-market trading. Conifer Holdings shares jumped 74% on Tuesday after the company announced that it completed the sale of its insurance agency operations for a $45 million consideration. The company appointed Brian Roney As CEO.
  • LogicMark, Inc. (NASDAQ:LGMK) gained 29.4% to $0.2618 in pre-market trading after gaining over 12% on Monday.
  • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) gained 17.2% to $7.99 in pre-market trading. The company announced a $36 million registered direct offering of 758900 shares at $8.25 per share.
  • Tantech Holdings Ltd (NASDAQ:TANH) gained 16% to $0.1613 in the pre-market trading session.
  • BTCS Inc. (NASDAQ:BTCS) gained 10% to $1.10 in pre-market trading after dipping around 15% on Tuesday.
  • Genelux Corporation (NASDAQ:GNLX) rose 9.1% to $2.27 in pre-market trading after declining around 4% on Tuesday.
  • Clover Health Investments, Corp. (NASDAQ:CLOV) gained 8.4% to $2.71 in pre-market trading after subsidiary Iowa Clinic signed a multi-year agreement with Counterpart Health to deploy AI technology across hundreds of Midwest providers.
  • Astera Labs, Inc. (NASDAQ:ALAB) gained 4% to $40.66 in pre-market trading after dipping 9% on Tuesday.

Losers

  • Athira Pharma, Inc. (NASDAQ:ATHA) fell 72.7% to $0.7739 in pre-market trading after the company announced its Phase 2/3 LIFT-AD clinical trial for Fosgonimeton in mild-to-moderate Alzheimer’s disease did not meet its primary or key secondary endpoints.
  • Oragenics, Inc. (NYSE:OGEN) shares fell 32.2% to $0.7254 in pre-market trading after dipping more than 15% on Tuesday. Oragenics, last month, announced the filing completion for its ONP-002 drug in anticipation of its Phase IIa clinical trail in concussed patients.
  • Focus Universal Inc. (NASDAQ:FCUV) shares fell 16.4% to $0.2530 in pre-market trading after gaining more than 12% on Tuesday.
  • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares declined 16.2% to $1.76 in pre-market trading. The company was granted #12077515 for selective histone deacetylase inhibitors.
  • Zscaler, Inc. (NASDAQ:ZS) fell 15.2% to $163.70 in pre-market trading following fourth-quarter earnings.
  • Asana, Inc. (NYSE:ASAN) shares declined 14.6% to $11.35 in pre-market trading. Asana reported upbeat results for its second quarter but issued weak guidance for the third quarter.
  • PagerDuty, Inc. (NYSE:PD) fell 14.4% to $15.66 in today's pre-market trading. PagerDuty reported better-than-expected earnings for its second quarter, while sales missed estimates.
  • Elevai Labs Inc. (NASDAQ:ELAB) shares fell 11.3% to $0.2839 in pre-market trading. Elevai Labs shares gained around 20% on Tuesday after its subsidiary, Elevai Skincare, announced data results that demonstrated the potential of its proprietary Elevai Exosomes in hair restoration.
  • Motorsport Games Inc. (NASDAQ:MSGM) shares dipped 11.3% to $1.16 in pre-market trading after gaining 10% on Tuesday.
  • Sify Technologies Limited (NASDAQ:SIFY) declined 9.6% to $0.5971 in pre-market trading after jumping around 100% on Tuesday.

Now Read This:

  • Dow Tumbles Over 600 Points, Nasdaq Dips 3% Amid Plunge In Nvidia: Fear Index Remains In ‘Greed’ Zone
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment